Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1CNS 1

Conditions

Breast Neoplasms 4Brain Neoplasms 4Glioma 3Uterine Cervical Neoplasms 1Turcot syndrome 1Rectal Neoplasms 1Prostatic Neoplasms 1Peripheral Nervous System Diseases 1Oligodendroglioma 1Neuritis 1Neoplasms 1Neoplasm Metastasis 1Medulloblastoma 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Gliosarcoma 1Glioblastoma 1Familial ependymoma 1Ependymoma 1Diffuse Intrinsic Pontine Glioma 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Colorectal Neoplasms 1Colonic Neoplasms 1Astrocytoma 1

Interventions

Filgrastim 13Temozolomide 9Carboplatin 8Peripheral Blood Stem Cell Transplantation 6Etoposide 5Cyclophosphamide 5sargramostim 4Magnetic Resonance Spectroscopy 4Irinotecan 4Erlotinib Hydrochloride 4Topotecan 3Thiotepa 3Radiotherapy 3Oxaliplatin 3O(6)-benzylguanine 3Granulocyte Colony-Stimulating Factor 3Busulfan 3etoposide phosphate 2Vorinostat 2Vincristine 2Specimen Handling 2Melphalan 2Ifosfamide 2Everolimus 2Cyproheptadine 2Cisplatin 2Carmustine 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2veliparib 1trioctyl phosphine oxide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Familial ependymoma × Diffusion Tensor Imaging × Clear all
NCT02359565 2026-05-13

Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma

National Cancer Institute (NCI)

Phase 1 Active not recruiting
71 enrolled
CNSGastrointestinal

Familial ependymoma, Turcot syndrome, Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, Ependymoma, Glioma, Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡